Aquinnah Pharmaceuticals' Series A Round

Aquinnah Pharmaceuticals raised a round of funding on December 21, 2015. Investors include Takeda Ventures.

Aquinnah Pharmaceuticals is a privately held biotechnology company focused on RNA binding proteins to slow the progression of ALS and other neurodegenerative diseases.…

Articles about Aquinnah Pharmaceuticals' Series A Round: